HFmrEF Archives - Cardiovascular News

$UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction$

12th December 2022

AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...

Write to us
Editorial: Will Date [email protected]
Advertising: Sean Langer [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: HFmrEF